Traws Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:TRAW Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
16 Apr 26	BuyUS$998,207	OrbiMed Advisors LLC	Company		597,729	US$1.67

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TRAW?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	605,531	4%
Individual Insiders	829,587	5.48%
VC/PE Firms	1,989,496	13.1%
Institutions	4,431,729	29.3%
General Public	7,294,326	48.1%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 172.3%.

Top Shareholders

Top 25 shareholders own 51.77% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.36%	Sirenia Capital Management LP	1,418,058	US$957.3k	0%	no data
7.94%	OrbiMed Advisors LLC	1,203,260	US$812.3k	98.7%	0.01%
5.19%	Ally Bridge Group	786,236	US$530.8k	0%	0.19%
4.82%	Adage Capital Management, L.P.	730,000	US$492.8k	0%	no data
4.48%	Ikarian Capital, LLC	678,142	US$457.8k	0%	0.06%
4%	Viriom Inc.	605,531	US$408.8k	0%	no data
3.59%	Jorey Chernett	543,268	US$366.8k	0%	no data
3.38%	Squadron Capital Management Llc	511,714	US$345.5k	-28.3%	0.13%
2.75%	Dauntless Investment Group, Llc	416,998	US$281.5k	0%	0.79%
1.28%	Boothbay Fund Management, LLC	194,536	US$131.3k	0%	no data
1.02%	ADAR1 Capital Management, LLC	154,098	US$104.0k	-0.22%	0.01%
0.64%	Werner Cautreels	96,348	US$65.0k	-2.03%	no data
0.53%	Nikolay Savchuk	80,517	US$54.4k	-3.64%	no data
0.53%	Iain Dukes	80,517	US$54.4k	-3.64%	no data
0.51%	Geode Capital Management, LLC	77,103	US$52.1k	25.1%	no data
0.4%	Palumbo Wealth Management LLC	61,175	US$41.3k	0%	0.01%
0.36%	Vanguard Capital Management, LLC	55,193	US$37.3k	0%	no data
0.21%	Vanguard Fiduciary Trust Company	31,804	US$21.5k	0%	no data
0.17%	State Street Global Advisors, Inc.	25,802	US$17.4k	0%	no data
0.16%	Robert Redfield	24,375	US$16.5k	0%	no data
0.14%	Jane Street Group, LLC	21,241	US$14.3k	0%	no data
0.13%	Two Sigma Investments, LP	19,244	US$13.0k	0%	no data
0.1%	Lynx1 Capital Management LP	15,078	US$10.2k	0%	no data
0.066%	BlackRock, Inc.	9,956	US$6.7k	0%	no data
0.027%	UBS Asset Management AG	4,053	US$2.7k	-47.5%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/10 00:28
End of Day Share Price	2026/07/10 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Traws Pharma, Inc. is covered by 10 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kimberly Lee	Brean Capital Historical (Janney Montgomery)
Michael Thomas Cooper	Edison Investment Research
Etzer Darout	Guggenheim Securities, LLC